EMMA International Consulting Group, Inc. and Thema srl Announce Strategic Partnership

This Strategic Partnership will enable EMMA International and Thema to Increase Their Geographical Offerings for the Medical Device Industry

EMMA International Consulting Group, Inc. (EMMA International) a global leader in quality, regulatory, and compliance services for the Biotechnology, Pharmaceuticals, and Medical Device industries, has entered into a strategic partnership with THEMA, an Italian based strategic-regulatory consulting company focused on medical and IVD devices.

The goal of this strategic partnership is to expand geographical offerings to companies operating in the life sciences regulated space.

“At EMMA International, we are thrilled to enter into this strategic partnership with THEMA to expand our service offerings in the EU market. This strategic partnership will expand resource offerings to our clients. Together, EMMA International and THEMA bring a wealth of knowledge in regulatory affairs, quality management and product development to the medical device industry,” stated Kira Jabri, COO.

“Through this partnership we can support Manufacturers expand in the target markets by analyzing their needs, being of help in solving their issues and providing them with the most accurate service within the US and the EU landscape, whether it means providing Local Representative or auditing services or through regulatory strategic support. EMMA International has been able to reach this goal and I believe their staff has put together something we can all rely on. Thanks to them we can now help our Clients face the QA/RA challenges in the US market more confidently.” stated Marisa Testa, CEO of Thema.

Through this strategic partnership, EMMA International and Thema will be able to expand their network and capabilities to support manufacturers around the globe.

SourceThema srl

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.